Laparoscopic treatment of polycystic ovaries: is it time to relinquish the procedure? (Q35196438)

7 August 2017

1 reference

title

Laparoscopic treatment of polycystic ovaries: is it time to relinquish the procedure? (English)

1 reference

7 August 2017

1 reference

2

Togas Tulandi

0 references

author name string

Imran Pirwany

series ordinal

1

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

7 August 2017

published in

Fertility and Sterility

1 reference

7 August 2017

volume

80

1 reference

7 August 2017

issue

2

1 reference

7 August 2017

page(s)

241-251

1 reference

Polycystic ovary syndrome

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

New approaches to insulin resistance in polycystic ovarian syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Further Clinical Experience with Clomiphene Citrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

An extended regimen of clomiphene citrate in women unresponsive to standard therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Pulsatile luteinizing hormone-releasing hormone therapy in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Distribution and characterization of insulin and insulin-like growth factor I receptors in normal human ovary.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Ovulation induction with low dose alternate day recombinant follicle stimulating hormone (Puregon).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Periovarian adhesions following ovarian wedge resection or laparoscopic biopsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Evaluation of adhesion reformation by early second-look laparoscopy following microlaser ovarian wedge resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Polycystic ovarian syndrome treated by ovarian electrocautery through the laparoscope.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Surgical management of polycystic ovarian syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Laparoscopic "drilling" by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Adhesion formation after laparoscopic electrocoagulation of the ovarian surface in polycystic ovary patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Long-term follow-up in 206 infertility patients with polycystic ovarian syndrome after laparoscopic electrocautery of the ovarian surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Laparoscopic ovarian treatment in infertile patients with polycystic ovarian syndrome (PCOS): endocrine changes and clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Factors affecting the outcome of laparoscopic ovarian drilling for polycystic ovarian syndrome in women with anovulatory infertility.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Laparoscopic treatment of polycystic ovaries with insulated needle cautery: a reappraisal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Ovarian size and response to laparoscopic ovarian electro-cauterization in polycystic ovarian disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Effect of laparoscopic ovarian electrocautery on ovarian response and outcome of treatment with gonadotropins in clomiphene citrate-resistant patients with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Treatment of polycystic ovary disease with laparoscopic low-watt bipolar electrocoagulation of the ovaries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Long term follow-up of patients with polycystic ovarian syndrome after laparoscopic ovarian drilling: clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Late endocrine effects of ovarian electrocautery in women with polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

The impact of ovarian laser surgery on the gonadotrophin secretion in women with polycystic ovarian disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Laparoscopic treatment of polycystic ovarian syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Hormonal response to electrocautery of the ovary in patients with polycystic ovarian disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Changes of bioactive luteinizing hormone after laparoscopic ovarian cautery in patients with polycystic ovarian syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Laparoscopic ovarian diathermy in the management of anovulatory infertility in women with polycystic ovaries: endocrine changes and clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Endocrine changes after laparoscopic ovarian cautery in polycystic ovarian syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

The effect of laparoscopic multiple punch resection of the ovary on hypothalamo-pituitary axis in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

A prospective study comparing unilateral and bilateral laparoscopic ovarian diathermy in women with the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Polycystic ovaries treated by laparoscopic laser vaporization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Ovarian electrocautery in the treatment of women with polycystic ovary syndrome (PCOS). Factors affecting the results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

An analysis of the outcome of microsurgical and laparoscopic adhesiolysis for chronic pelvic pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Polycystic ovarian disease treated by laparoscopic argon laser capsule drilling: comparison of vaporization versus perforation technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Treatment of anovulation due to polycystic ovarian syndrome by laparoscopic ovarian electrocautery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Adhesion formation after ovarian electrocauterization on patients with polycystic ovarian syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Does laparoscopic ovarian diathermy affect the outcome of IVF-embryo transfer in women with polycystic ovarian syndrome? A retrospective comparative study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

In vitro fertilization following laparoscopic ovarian diathermy in patients with polycystic ovarian syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

The use of laparoscopic ovarian electrocautery in preventing cancellation of in-vitro fertilization treatment cycles due to risk of ovarian hyperstimulation syndrome in women with polycystic ovaries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Hypersecretion of luteinising hormone, infertility, and miscarriage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Recurrent early miscarriage and polycystic ovaries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Recurrent miscarriage: screening for polycystic ovaries and subsequent pregnancy outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Influence of past reproductive performance on risk of spontaneous abortion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

The use of human gonadotropins for the induction of ovulation in women with polycystic ovarian disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Effect of insulin-like growth factor-type I (IGF-I) and insulin on the secretion of sex hormone binding globulin and IGF-I binding protein (IBP-I) by human hepatoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Effects of laparoscopic ovarian drilling on adrenal steroids in polycystic ovary syndrome patients with and without hyperinsulinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

The polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Insulin resistance in nonobese patients with polycystic ovarian disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Ovarian electrocauterization causes LH‐regulated but not insulin‐regulated endocrine changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Effects of the insulin sensitizing drug metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhoea.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Menstrual cyclicity after metformin therapy in polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Consensus Development Conference on Insulin Resistance. 5-6 November 1997. American Diabetes Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Effects of metformin on early pregnancy loss in the polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Insulin-lowering medications in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

The effect of metformin on hirsutism in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Metformin improves ovulation and pregnancy rates in patients with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Mortality of women with polycystic ovary syndrome at long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Adhesions after ovarian drilling and intercede

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Post-operative adhesions after laparoscopic electrosurgical treatment for polycystic ovarian syndrome with the application of Interceed to one ovary: a prospective randomized controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Evaluation of adhesion formation after laparoscopic treatment of polycystic ovarian disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Adhesion formation after laparoscopic ovarian cautery for polycystic ovarian syndrome: lack of correlation with pregnancy rate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Laparoscopic electrocoagulation of the ovarian surface in infertile patients with polycystic ovarian disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

Treatment with pulsatile luteinizing hormone-releasing hormone modulates folliculogenesis in response to ovarian stimulation with exogenous gonadotropins in patients with polycystic ovaries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Ovarian electrocautery: responders versus non-responders

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900875-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0015-0282(03)00875-6

1 reference

7 August 2017

1 reference